{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T23:57:44Z","timestamp":1790812664966,"version":"4.1.0"},"reference-count":154,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.prp.2023.154379","type":"journal-article","created":{"date-parts":[[2023,2,17]],"date-time":"2023-02-17T12:09:34Z","timestamp":1676635774000},"page":"154379","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Urachal carcinoma: The journey so far and the road ahead"],"prefix":"10.1016","volume":"243","author":[{"given":"Rajesh","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seetha","family":"Harilal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed A.","family":"Abdelgawad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed M.","family":"Ghoneim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bijo","family":"Mathew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2023.154379_bib1","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.juro.2012.06.020","article-title":"The clinical epidemiology of urachal carcinoma: results of a large, population based study","volume":"188","author":"Bruins","year":"2012","journal-title":"J. Urol."},{"key":"10.1016\/j.prp.2023.154379_bib2","series-title":"Semin. Oncol.","first-page":"619","article-title":"Urachal adenocarcinoma: a clinician\u2019s guide for treatment","author":"Siefker-Radtke","year":"2012"},{"key":"10.1016\/j.prp.2023.154379_bib3","doi-asserted-by":"crossref","first-page":"S1307","DOI":"10.21037\/tcr.2016.12.28","article-title":"Urachal carcinoma: towards a precision medicine","volume":"5","author":"Mennitto","year":"2016","journal-title":"Transl. Cancer Res."},{"key":"10.1016\/j.prp.2023.154379_bib4","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1097\/PAS.0b013e3182189c11","article-title":"Immunohistochemical analysis in a morphologic spectrum of urachal epithelial neoplasms: diagnostic implications and pitfalls","volume":"35","author":"Paner","year":"2011","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2023.154379_bib5","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1097\/PAS.0b013e31819aa4ae","article-title":"Urachal carcinoma: a clinicopathologic analysis of 24 cases with outcome correlation","volume":"33","author":"Gopalan","year":"2009","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2023.154379_bib6","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0022-5347(17)53595-8","article-title":"Tubular urachal remnants in adult bladders","volume":"127","author":"Schubert","year":"1982","journal-title":"J. Urol."},{"key":"10.1016\/j.prp.2023.154379_bib7","doi-asserted-by":"crossref","first-page":"20190118","DOI":"10.1259\/bjr.20190118","article-title":"The urachus revisited: multimodal imaging of benign & malignant urachal pathology","volume":"93","author":"Das","year":"2020","journal-title":"Br. J. Radiol."},{"key":"10.1016\/j.prp.2023.154379_bib8","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1002\/cncr.22060","article-title":"Urachal carcinoma: clinicopathologic features and long-term outcomes of an aggressive malignancy","volume":"107","author":"Ashley","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.prp.2023.154379_bib9","first-page":"372","article-title":"Urachal remnants: an enigma","volume":"13","author":"Upadhyay","year":"2003","journal-title":"Eur. J. Pediatr. Surg. Off. J. Austrian Assoc. Pediatr. Surg. Al Z. Kinderchir."},{"key":"10.1016\/j.prp.2023.154379_bib10","first-page":"418","article-title":"Cancer coloide de la lom-bille et de paroi abdominale ante-rieure avant envahi la vessie","volume":"6","author":"Hue","year":"1863","journal-title":"Union Med Seine Inf. Rouen."},{"key":"10.1016\/j.prp.2023.154379_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-016-2209-1","article-title":"Clinical application of genomic profiling to find druggable targets for adolescent and young adult (AYA) cancer patients with metastasis","volume":"16","author":"Cha","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1016\/j.prp.2023.154379_bib12","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1002\/1097-0142(1955)8:4<741::AID-CNCR2820080417>3.0.CO;2-C","article-title":"Mucous adenocarcinoma of the urinary bladder","volume":"8","author":"Mostofi","year":"1955","journal-title":"Cancer"},{"key":"10.1016\/j.prp.2023.154379_bib13","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/1097-0142(195401)7:1<119::AID-CNCR2820070113>3.0.CO;2-8","article-title":"Adenocarcinoma involving the urinary bladder","volume":"7","author":"Wheeler","year":"1954","journal-title":"Cancer"},{"key":"10.1016\/j.prp.2023.154379_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-5347(17)50167-6","article-title":"Malignant urachal lesions","volume":"131","author":"Sheldon","year":"1984","journal-title":"J. Urol."},{"key":"10.1016\/j.prp.2023.154379_bib15","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1002\/1097-0142(19910415)67:8<2165::AID-CNCR2820670827>3.0.CO;2-M","article-title":"Primary adenocarcinoma of the urinary bladder. A clinicopathologic analysis of 72 cases","volume":"67","author":"Grignon","year":"1991","journal-title":"Cancer"},{"key":"10.1016\/j.prp.2023.154379_bib16","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.juro.2007.03.022","article-title":"Urachal carcinoma: contemporary surgical outcomes","volume":"178","author":"Herr","year":"2007","journal-title":"J. Urol."},{"key":"10.1016\/j.prp.2023.154379_bib17","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1097\/PAS.0b013e31823fe49c","article-title":"Urachal carcinomas of the nonglandular type: salient features and considerations in pathologic diagnosis","volume":"36","author":"Paner","year":"2012","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2023.154379_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11912-020-0878-z","article-title":"Current understanding of urachal adenocarcinoma and management strategy","volume":"22","author":"Claps","year":"2020","journal-title":"Curr. Oncol. Rep."},{"key":"10.1016\/j.prp.2023.154379_bib19","doi-asserted-by":"crossref","first-page":"97","DOI":"10.4081\/rt.2016.6257","article-title":"National incidence, management and survival of urachal carcinoma","volume":"8","author":"Collins","year":"2016","journal-title":"Rare Tumors"},{"key":"10.1016\/j.prp.2023.154379_bib20","series-title":"Urol. Oncol. Semin. Orig. Investig.","first-page":"33","article-title":"Malignant urachal neoplasms: a population-based study and systematic review of literature","author":"Mylonas","year":"2017"},{"key":"10.1016\/j.prp.2023.154379_bib21","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.3892\/ol.2014.2502","article-title":"Investigating urachal carcinoma for more than 15 years","volume":"8","author":"Chen","year":"2014","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.prp.2023.154379_bib22","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1016\/j.humpath.2015.07.021","article-title":"Urachal carcinoma: a pathologic and clinical study of 46 cases","volume":"46","author":"Dhillon","year":"2015","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.prp.2023.154379_bib23","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1016\/j.juro.2015.11.067","article-title":"Urachal carcinoma of the bladder: impact of clinical and immunohistochemical parameters on prognosis","volume":"195","author":"Niedworok","year":"2016","journal-title":"J. Urol."},{"key":"10.1016\/j.prp.2023.154379_bib24","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00292-018-0516-9","article-title":"Urachal cancer\u2014current concepts of a rare cancer","volume":"40","author":"Reis","year":"2019","journal-title":"Pathol"},{"key":"10.1016\/j.prp.2023.154379_bib25","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00428-018-2467-1","article-title":"Urachal carcinoma: from gross specimen to morphologic, immunohistochemical, and molecular analysis","volume":"474","author":"Riva","year":"2019","journal-title":"Virchows Arch."},{"key":"10.1016\/j.prp.2023.154379_bib26","series-title":"Urol. Oncol. Semin. Orig. Investig.","first-page":"388","article-title":"Clinical, prognostic, and therapeutic aspects of urachal carcinoma\u2014a comprehensive review with meta-analysis of 1,010 cases","author":"Szarvas","year":"2016"},{"key":"10.1016\/j.prp.2023.154379_bib27","doi-asserted-by":"crossref","DOI":"10.1186\/s40880-016-0173-4","article-title":"Clinical comparison of patients with benign urachal masses versus urachal carcinomas","volume":"36","author":"Bi","year":"2017","journal-title":"Chin. J. Cancer"},{"issue":"2018","key":"10.1016\/j.prp.2023.154379_bib28","article-title":"Biomarkers in urachal cancer and adenocarcinomas in the bladder: a comprehensive review supplemented by own data","author":"Reis","year":"2018","journal-title":"Dis. Markers"},{"key":"10.1016\/j.prp.2023.154379_bib29","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1097\/PAS.0000000000000250","article-title":"Glandular neoplasms of the urachus: a report of 55 cases emphasizing mucinous cystic tumors with proposed classification","volume":"38","author":"Amin","year":"2014","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2023.154379_bib30","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/PAP.0000000000000110","article-title":"Updates in the pathologic diagnosis and classification of epithelial neoplasms of urachal origin","volume":"23","author":"Paner","year":"2016","journal-title":"Adv. Anat. Pathol."},{"key":"10.1016\/j.prp.2023.154379_bib31","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1038\/modpathol.3880213","article-title":"Epithelioid leiomyosarcoma in a non-immunocompromised infant: additional differential diagnosis of pediatric \u201cround cell tumors","volume":"13","author":"Kato","year":"2000","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.prp.2023.154379_bib32","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1111\/j.1442-2042.2007.01826.x","article-title":"A case of spontaneous rupture perforation of leiomyosarcoma in the urachus of a young boy","volume":"14","author":"Kim","year":"2007","journal-title":"Int. J. Urol."},{"key":"10.1016\/j.prp.2023.154379_bib33","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0090-4295(81)90053-4","article-title":"Urachal leiomyosarcoma","volume":"17","author":"Noyes","year":"1981","journal-title":"Urology"},{"key":"10.1016\/j.prp.2023.154379_bib34","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1177\/000313481207800911","article-title":"Traumatic intraperitoneal rupture of an urachal leiomyosarcoma: unique presentation as hemorrhagic shock","volume":"78","author":"Saied","year":"2012","journal-title":"Am. Surg."},{"key":"10.1016\/j.prp.2023.154379_bib35","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1001\/archsurg.1961.01300090113024","article-title":"Sarcoma of the Urachus","volume":"82","author":"WHITTLE","year":"1961","journal-title":"Arch. Surg."},{"key":"10.1016\/j.prp.2023.154379_bib36","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/j.jpedsurg.2014.12.023","article-title":"Urachal rhabdomyosarcoma in childhood: a rare entity with a poor outcome","volume":"50","author":"Cheikhelard","year":"2015","journal-title":"J. Pediatr. Surg."},{"key":"10.1016\/j.prp.2023.154379_bib37","first-page":"226","article-title":"Inflammatory fibrosarcoma of the urachus: a case report","volume":"75","author":"Lacquaniti","year":"2003","journal-title":"Arch. Ital. Urol. Androl. Organo Uff. Soc. Ital. Ecogr. Urol. E Nefrol."},{"key":"10.1016\/j.prp.2023.154379_bib38","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/BF01889085","article-title":"Extraretroperitoneal abdominal malignant fibrous histiocytoma","volume":"13","author":"Bruneton","year":"1988","journal-title":"Gastrointest. Radiol."},{"key":"10.1016\/j.prp.2023.154379_bib39","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1002\/cncr.23070","article-title":"Predictors of survival from urachal","volume":"110","author":"Molina","year":"2007","journal-title":"Cancer, Cancer"},{"key":"10.1016\/j.prp.2023.154379_bib40","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1002\/bjs.18004821214","article-title":"Sarcoma of the urachus","volume":"48","author":"Powley","year":"1961","journal-title":"BJS Br. J. Surg."},{"key":"10.1016\/j.prp.2023.154379_bib41","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1001\/archsurg.1959.04320110026004","article-title":"Sarcoma of the urachus","volume":"79","author":"BUTLER","year":"1959","journal-title":"AMA Arch. Surg."},{"key":"10.1016\/j.prp.2023.154379_bib42","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/bjs.18003714518","article-title":"Sarcoma of the urachus report of a case and brief review of the subject","volume":"37","author":"Shaw","year":"1949","journal-title":"BJS Br. J. Surg."},{"key":"10.1016\/j.prp.2023.154379_bib43","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1002\/ijc.31547","article-title":"Pathogenic and targetable genetic alterations in 70 urachal adenocarcinomas","volume":"143","author":"Reis","year":"2018","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.prp.2023.154379_bib44","series-title":"World Health Organ. Classif. Tumours Urin. Syst","first-page":"113","article-title":"Urachal carcinoma","author":"Lopez-Beltran","year":"2016"},{"key":"10.1016\/j.prp.2023.154379_bib45","first-page":"17","article-title":"Two cases of lower abdominal tumors difficult to differentiate from urachal tumors]","volume":"105","author":"Mizusawa","year":"2014","journal-title":"Nihon Hinyokika Gakkai Zasshi Jpn. J. Urol."},{"key":"10.1016\/j.prp.2023.154379_bib46","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.urology.2004.02.037","article-title":"Urachal inflammatory myofibroblastic tumor with ALK gene rearrangement: a study of urachal remnants","volume":"64","author":"Nascimento","year":"2004","journal-title":"Urology"},{"issue":"1983","key":"10.1016\/j.prp.2023.154379_bib47","first-page":"1374","article-title":"Inflammatory pseudotumor of the urachus. A case","volume":"21","author":"Kaskas","year":"1992","journal-title":"Presse Med. Paris Fr."},{"key":"10.1016\/j.prp.2023.154379_bib48","first-page":"93","article-title":"Anaplastic lymphoma kinase positive inflammatory myofibroblastic tumor of the urachus: a rare neoplasm in an unusual location","volume":"59","author":"Venkatesh","year":"2016","journal-title":"Indian J. Pathol. Microbiol"},{"key":"10.1016\/j.prp.2023.154379_bib49","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/S0022-5347(17)64196-X","article-title":"Hemangiopericytoma of Urachus: report of a Case","volume":"91","author":"Baglio","year":"1964","journal-title":"J. Urol."},{"key":"10.1016\/j.prp.2023.154379_bib50","first-page":"386","article-title":"[Pelvic fibromatosis simulating urachal tumor\u2013a case report], Nihon Hinyokika Gakkai Zasshi Jpn","volume":"84","author":"Iuchi","year":"1993","journal-title":"J. Urol."},{"key":"10.1016\/j.prp.2023.154379_bib51","first-page":"489","article-title":"A case of abdominal desmoid tumor that was difficult to differentiate from urachal tumor","volume":"50","author":"Sugi","year":"2004","journal-title":"Hinyokika Kiyo"},{"key":"10.1016\/j.prp.2023.154379_bib52","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.urology.2004.04.020","article-title":"Castleman\u2019s disease of the urachus","volume":"64","author":"Rudloff","year":"2004","journal-title":"Urology"},{"key":"10.1016\/j.prp.2023.154379_bib53","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S0301-2115(01)00459-6","article-title":"A urachal leiomyoma misdiagnosed as an ovarian tumor","volume":"100","author":"Ramazan","year":"2001","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.prp.2023.154379_bib54","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1034\/j.1600-0412.2003.00099.x","article-title":"Urachal myoma: a case report","volume":"82","author":"Ding","year":"2003","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"10.1016\/j.prp.2023.154379_bib55","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1046\/j.1464-410x.1998.00456.x","article-title":"Benign teratoma of the urachus","volume":"81","author":"Defabiani","year":"1998","journal-title":"Br. J. Urol."},{"key":"10.1016\/j.prp.2023.154379_bib56","first-page":"471","article-title":"A case of teratoma of the urachus","volume":"46","author":"Cionfoli","year":"1991","journal-title":"Minerva Chir."},{"key":"10.1016\/j.prp.2023.154379_bib57","first-page":"1393","article-title":"Hamartoma of the urachal remnant","volume":"113","author":"Park","year":"1989","journal-title":"Arch. Pathol. Lab. Med."},{"key":"10.1016\/j.prp.2023.154379_bib58","first-page":"1047","article-title":"Fibrous hamartoma of the urachus. Report of a case complicated by strangulation of the stalk","volume":"53","author":"Panero","year":"1998","journal-title":"Minerva Chir."},{"key":"10.1016\/j.prp.2023.154379_bib59","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0368-2315(06)76375-X","article-title":"Kyste dermo\u00efde de l\u2019ouraque: \u00e0 propos d\u2019un cas et revue de la litt\u00e9rature","volume":"35","author":"Agbreta","year":"2006","journal-title":"J. Gyn\u00e9cologie Obst\u00e9trique Biol. Reprod."},{"key":"10.1016\/j.prp.2023.154379_bib60","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0022-5347(17)59844-4","article-title":"Fibroadenoma of the Urachus","volume":"112","author":"Loening","year":"1974","journal-title":"J. Urol."},{"key":"10.1016\/j.prp.2023.154379_bib61","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/RLU.0b013e31827a263e","article-title":"Organized urachal abscess mimicking urachal carcinoma on FDG PET\/CT","volume":"39","author":"Dong","year":"2014","journal-title":"Clin. Nucl. Med"},{"key":"10.1016\/j.prp.2023.154379_bib62","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/PEC.0000000000000353","article-title":"Ultrasound evaluation of urachal abscess in a young infant","volume":"31","author":"McConnell","year":"2015","journal-title":"Pediatr. Emerg. Care."},{"key":"10.1016\/j.prp.2023.154379_bib63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1752-1947-6-226","article-title":"Abscess of urachal remnants presenting with acute abdomen: a case series","volume":"6","author":"Tazi","year":"2012","journal-title":"J. Med. Case Rep."},{"key":"10.1016\/j.prp.2023.154379_bib64","first-page":"45","article-title":"Hemangioma of the urachus","author":"Ukhal\u2019","year":"1993","journal-title":"Urol. Nefrol. (Mosk. )."},{"key":"10.1016\/j.prp.2023.154379_bib65","doi-asserted-by":"crossref","first-page":"443.e13","DOI":"10.1016\/j.urology.2008.02.045","article-title":"Xanthogranulomatous inflammation of urachus mimicking urachal carcinoma","volume":"73","author":"Kuo","year":"2009","journal-title":"Urology"},{"key":"10.1016\/j.prp.2023.154379_bib66","doi-asserted-by":"crossref","first-page":"114","DOI":"10.5152\/balkanmedj.2015.15053","article-title":"A case of urachal malacoplakia that seems like urachal cancer","volume":"32","author":"\u0130nci","year":"2015","journal-title":"Balk. Med. J."},{"key":"10.1016\/j.prp.2023.154379_bib67","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/S0090-4295(01)01189-X","article-title":"Primary actinomycosis mimicking urachal carcinoma","volume":"58","author":"Yeung","year":"2001","journal-title":"Urology"},{"key":"10.1016\/j.prp.2023.154379_bib68","first-page":"141","article-title":"Actinomycosis in persistent urachus","volume":"67","author":"Bednarek","year":"2010","journal-title":"Przegl. Lek."},{"key":"10.1016\/j.prp.2023.154379_bib69","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jcma.2011.01.007","article-title":"Imaging findings of primary urachal actinomycosis","volume":"74","author":"Li","year":"2011","journal-title":"J. Chin. Med. Assoc."},{"key":"10.1016\/j.prp.2023.154379_bib70","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3904\/kjim.2013.28.1.103","article-title":"Tuberculosis of the urachal cyst","volume":"28","author":"Jindal","year":"2013","journal-title":"Korean J. Intern. Med"},{"key":"10.1016\/j.prp.2023.154379_bib71","first-page":"144","article-title":"Perforated colonic diverticulitis mimicking urachal carcinoma: computed tomography and magnetic resonance findings","volume":"29","author":"Takao","year":"2005","journal-title":"Clin. Imaging"},{"key":"10.1016\/j.prp.2023.154379_bib72","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/uog.8985","article-title":"Polypoid endometriosis of the bladder during pregnancy mimicking urachal carcinoma","volume":"38","author":"Lambrechts","year":"2011","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"10.1016\/j.prp.2023.154379_bib73","doi-asserted-by":"crossref","first-page":"655","DOI":"10.21037\/tau.2016.04.01","article-title":"Genetics and biological markers in urachal cancer","volume":"5","author":"Behrendt","year":"2016","journal-title":"Transl. Androl. Urol."},{"key":"10.1016\/j.prp.2023.154379_bib74","first-page":"51","article-title":"Adenocarcinoma of the urinary bladder","volume":"3","author":"Dadhania","year":"2015","journal-title":"Am. J. Clin. Exp. Urol."},{"key":"10.1016\/j.prp.2023.154379_bib75","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1097\/01.ju.0000054646.49381.01","article-title":"Multimodality Management of Urachal Carcinoma: The M. D. Anderson Cancer Center Experience","volume":"169","author":"Siefker-radtke","year":"2003","journal-title":"J. Urol."},{"key":"10.1016\/j.prp.2023.154379_bib76","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1016\/S0022-5347(06)00263-1","article-title":"Population based survival data on urachal tumors","volume":"175","author":"Pinthus","year":"2006","journal-title":"J. Urol."},{"key":"10.1016\/j.prp.2023.154379_bib77","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/1746-1596-7-151","article-title":"Primary bladder adenocarcinoma versus metastatic colorectal adenocarcinoma: a persisting diagnostic challenge","volume":"7","author":"Roy","year":"2012","journal-title":"Diagn. Pathol."},{"key":"10.1016\/j.prp.2023.154379_bib78","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/01.pai.0000136552.44045.0f","article-title":"Immunohistochemistry in the differential diagnosis between primary and secondary intestinal adenocarcinoma of the urinary bladder","volume":"13","author":"Raspollini","year":"2005","journal-title":"Appl. Immunohistochem. Mol. Morphol."},{"key":"10.1016\/j.prp.2023.154379_bib79","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1097\/01.MP.0000086073.92773.55","article-title":"Cdx2 Protein Expression in Normal and Malignant Human Tissues: An Immunohistochemical Survey Using Tissue Microarrays","volume":"16","author":"Moskaluk","year":"2003","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.prp.2023.154379_bib80","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/00000478-200303000-00003","article-title":"CDX2, a highly sensitive and specific marker of adenocarcinomas of intestinal origin: An immunohistochemical survey of 476 primary and metastatic carcinomas","volume":"27","author":"WERLING","year":"2003","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2023.154379_bib81","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1136\/jclinpath-2015-203144","article-title":"Differential diagnosis of bladder versus colorectal adenocarcinoma: keratin 7 and GATA3 positivity in nuclear \u00df-catenin-negative glandular tumours defines adenocarcinoma of the bladder","volume":"69","author":"Broede","year":"2016","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.prp.2023.154379_bib82","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1038\/modpathol.3800670","article-title":"Divergent pathway of intestinal metaplasia and cystitis glandularis of the urinary bladder","volume":"19","author":"Sung","year":"2006","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.prp.2023.154379_bib83","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0210-4806(04)73048-X","article-title":"Expresi\u00f3n de cdx2 en lesiones de vejiga urinaria y uretra","volume":"28","author":"Ortiz-rer","year":"2004","journal-title":"Actas Urol. Esp."},{"key":"10.1016\/j.prp.2023.154379_bib84","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.devcel.2009.06.016","article-title":"Wnt\/\u03b2-catenin signaling: components, mechanisms, and diseases","volume":"17","author":"MacDonald","year":"2009","journal-title":"Dev. Cell."},{"key":"10.1016\/j.prp.2023.154379_bib85","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S0344-0338(98)80129-5","article-title":"Nuclear overexpression of the oncoprotein \u03b2-catenin in colorectal cancer is localized predominantly at the invasion front","volume":"194","author":"Brabletz","year":"1998","journal-title":"Pathol.\u00a0Res. Pr."},{"key":"10.1016\/j.prp.2023.154379_bib86","doi-asserted-by":"crossref","first-page":"29211","DOI":"10.18632\/oncotarget.8640","article-title":"Whole exome sequencing of urachal adenocarcinoma reveals recurrent NF1 mutations","volume":"7","author":"Singh","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.prp.2023.154379_bib87","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.eururo.2016.04.037","article-title":"Urachal carcinoma shares genomic alterations with colorectal carcinoma and may respond to epidermal growth factor inhibition","volume":"70","author":"Collazo-Lorduy","year":"2016","journal-title":"Eur. Urol."},{"key":"10.1016\/j.prp.2023.154379_bib88","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/j.1440-1827.2010.02587.x","article-title":"Immunohistochemical analysis of colorectal cancer with gastric phenotype: claudin-18 is associated with poor prognosis","volume":"60","author":"Matsuda","year":"2010","journal-title":"Pathol. Int"},{"key":"10.1016\/j.prp.2023.154379_bib89","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s00428-011-1092-z","article-title":"Claudin-18 in biliary neoplasms. Its significance in the classification of intrahepatic cholangiocarcinoma","volume":"459","author":"Shinozaki","year":"2011","journal-title":"Virchows Arch."},{"key":"10.1016\/j.prp.2023.154379_bib90","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0074757","article-title":"Down-regulation of claudin-18 is associated with the proliferative and invasive potential of gastric cancer at the invasive front","volume":"8","author":"Oshima","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.prp.2023.154379_bib91","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1046\/j.1365-2559.1998.00328.x","article-title":"Value of a panel of antibodies to identify the primary origin of adenocarcinomas presenting as bladder carcinoma","volume":"32","author":"Torenbeek","year":"1998","journal-title":"Histopathology"},{"key":"10.1016\/j.prp.2023.154379_bib92","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1002\/path.1922","article-title":"Down-regulation of the claudin-18 gene, identified through serial analysis of gene expression data analysis, in gastric cancer with an intestinal phenotype","volume":"208","author":"Sanada","year":"2006","journal-title":"J. Pathol."},{"key":"10.1016\/j.prp.2023.154379_bib93","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1056\/NEJMoa1500596","article-title":"PD-1 blockade in tumors with mismatch-repair deficiency","volume":"372","author":"Le","year":"2015","journal-title":"New Engl. J. Med"},{"key":"10.1016\/j.prp.2023.154379_bib94","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1111\/j.1442-2042.2004.00940.x","article-title":"Large intestinal type-urachal adenocarcinoma with focal expression of prostatic specific antigen","volume":"11","author":"Kato","year":"2004","journal-title":"Int. J. Urol."},{"key":"10.1016\/j.prp.2023.154379_bib95","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/apm.12504","article-title":"Immunohistochemistry of ductal adenocarcinoma of the prostate and adenocarcinomas of non-prostatic origin: a comparative study","volume":"124","author":"Seipel","year":"2016","journal-title":"APMIS"},{"key":"10.1016\/j.prp.2023.154379_bib96","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1038\/modpathol.3800407","article-title":"Value of CDX2, villin, and \u03b1-methylacyl coenzyme A racemase immunostains in the distinction between primary adenocarcinoma of the bladder and secondary colorectal adenocarcinoma","volume":"18","author":"Suh","year":"2005","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.prp.2023.154379_bib97","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/modpathol.2012.229","article-title":"Distinguishing primary adenocarcinoma of the urinary bladder from secondary involvement by colorectal adenocarcinoma: extended immunohistochemical profiles emphasizing novel markers","volume":"26","author":"Rao","year":"2013","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.prp.2023.154379_bib98","first-page":"630","article-title":"An immunohistochemical study of primary signet-ring cell carcinoma of the stomach and colorectum: III. Expressions of EMA, CEA, CA19-9, CDX-2, p53, Ki-67 antigen, TTF-1, vimentin, and p63 in normal mucosa and in 42 cases","volume":"6","author":"Terada","year":"2013","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.prp.2023.154379_bib99","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/ajcp\/107.1.12","article-title":"Immunohistochemical identification of tumor markers in metastatic adenocarcinoma. A diagnostic adjunct in the determination of primary site","volume":"107","author":"Brown","year":"1997","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.prp.2023.154379_bib100","first-page":"1065","article-title":"Urachal carcinoma producing carcinoembryonic antigen: a case report","volume":"35","author":"Arai","year":"1989","journal-title":"Hinyokika Kiyo"},{"key":"10.1016\/j.prp.2023.154379_bib101","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1097\/PAS.0b013e31829cdba7","article-title":"GATA-3 immunohistochemistry in the differential diagnosis of adenocarcinoma of the urinary bladder","volume":"37","author":"Ellis","year":"2013","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2023.154379_bib102","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1309\/DFJUHY3WPC9GUU2W","article-title":"Chromosomal alterations detected by fluorescence in situ hybridization in urothelial carcinoma and rarer histologic variants of bladder cancer","volume":"130","author":"Kipp","year":"2008","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.prp.2023.154379_bib103","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/01.MP.0000067683.84284.66","article-title":"Expression of mucins and cytokeratins in primary carcinomas of the digestive system","volume":"16","author":"Lee","year":"2003","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.prp.2023.154379_bib104","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1038\/modpathol.2013.101","article-title":"Expression of MUC2, MUC5AC, MUC5B, and MUC6 mucins in colorectal cancers and their association with the CpG island methylator phenotype","volume":"26","author":"Walsh","year":"2013","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.prp.2023.154379_bib105","doi-asserted-by":"crossref","first-page":"5529","DOI":"10.4081\/rt.2014.5529","article-title":"Response to targeted therapy in urachal adenocarcinoma","volume":"6","author":"Testa","year":"2014","journal-title":"Rare Tumors"},{"key":"10.1016\/j.prp.2023.154379_bib106","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1016\/S0022-5347(01)64109-0","article-title":"Adenocarcinoma of the urachus and bladder expresses a unique colonic epithelial epitope: an immunohistochemical study","volume":"158","author":"Pantuck","year":"1997","journal-title":"J. Urol."},{"key":"10.1016\/j.prp.2023.154379_bib107","doi-asserted-by":"crossref","DOI":"10.1016\/S0022-5347(05)67925-6","article-title":"\u03b1-Fetoprotein producing urachal tumor","volume":"163","author":"KISE","year":"2000","journal-title":"J. Urol."},{"key":"10.1016\/j.prp.2023.154379_bib108","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.humpath.2013.09.008","article-title":"High-stage urachal adenocarcinoma can be associated with microsatellite instability and KRAS mutations","volume":"45","author":"Sirintrapun","year":"2014","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.prp.2023.154379_bib109","first-page":"00027","article-title":"Comprehensive molecular characterization of urachal adenocarcinoma reveals commonalities with colorectal cancer, including a hypermutable phenotype","volume":"1","author":"Kardos","year":"2017","journal-title":"JCO Precis. Oncol."},{"key":"10.1016\/j.prp.2023.154379_bib110","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1007\/s12253-020-00872-6","article-title":"Prevalence of APC and PTEN alterations in urachal cancer","volume":"26","author":"Nagy","year":"2020","journal-title":"Pathol. Oncol. Res."},{"key":"10.1016\/j.prp.2023.154379_bib111","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2015.00288","article-title":"Targeting oncogenic Mutant p53 for cancer therapy","volume":"5","author":"Parrales","year":"2015","journal-title":"Front. Oncol."},{"key":"10.1016\/j.prp.2023.154379_bib112","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/pin.12594","article-title":"Telomerase reverse transcriptase (TERT) promoter mutations are rare in urachal cancer","volume":"67","author":"Thiem","year":"2017","journal-title":"Pathol. Int."},{"key":"10.1016\/j.prp.2023.154379_bib113","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1038\/ncomms3185","article-title":"Frequency of TERT promoter mutations in human cancers","volume":"4","author":"Vinagre","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.prp.2023.154379_bib114","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.eururo.2013.10.038","article-title":"Telomerase reverse transcriptase gene promoter mutations help discern the origin of urogenital tumors: a genomic and molecular study","volume":"65","author":"Wu","year":"2014","journal-title":"Eur. Urol."},{"key":"10.1016\/j.prp.2023.154379_bib115","doi-asserted-by":"crossref","first-page":"852","DOI":"10.3109\/0284186X.2014.895036","article-title":"The predictive value of KRAS, NRAS, BRAF, PIK3CA and PTEN for anti-EGFR treatment in metastatic colorectal cancer: a systematic review and meta-analysis","volume":"53","author":"Therkildsen","year":"2014","journal-title":"Acta Oncol."},{"key":"10.1016\/j.prp.2023.154379_bib116","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0140-6736(10)61121-X","article-title":"Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial","volume":"376","author":"Bang","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.prp.2023.154379_bib117","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1056\/NEJM200103153441101","article-title":"Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2","volume":"344","author":"Slamon","year":"2001","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.prp.2023.154379_bib118","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nature11252","article-title":"Comprehensive molecular characterization of human colon and rectal cancer","volume":"487","author":"Muzny","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.prp.2023.154379_bib119","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1136\/jmedgenet-2016-104390","article-title":"Comprehensive somatic genome alterations of urachal carcinoma","volume":"54","author":"Lee","year":"2017","journal-title":"J. Med. Genet"},{"key":"10.1016\/j.prp.2023.154379_bib120","doi-asserted-by":"crossref","first-page":"39293","DOI":"10.18632\/oncotarget.9828","article-title":"Mutations of KRAS, NRAS, BRAF, EGFR, and PIK3CA genes in urachal carcinoma: occurence and prognostic significance","volume":"7","author":"M\u00f3dos","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.prp.2023.154379_bib121","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2018-226207","article-title":"Urachal adenocarcinoma","volume":"2018","author":"Aggarwal","year":"2018","journal-title":"BMJ Case Rep."},{"key":"10.1016\/j.prp.2023.154379_bib122","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/j.1464-410X.1971.tb12070.x","article-title":"Carcinoma of the urachus","volume":"43","author":"Whitehead","year":"1971","journal-title":"Br. J. Urol."},{"key":"10.1016\/j.prp.2023.154379_bib123","doi-asserted-by":"crossref","first-page":"423.e15","DOI":"10.1016\/j.urology.2005.08.044","article-title":"Laparoscopic partial cystectomy for treatment of adenocarcinoma of the urachus","volume":"67","author":"Milhoua","year":"2006","journal-title":"Urology"},{"key":"10.1016\/j.prp.2023.154379_bib124","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/S0090-4295(96)00574-2","article-title":"Is partial cystectomy the treatment of choice for mucinous adenocarcinoma of the urachus","volume":"49","author":"Santucci","year":"1997","journal-title":"Urology"},{"key":"10.1016\/j.prp.2023.154379_bib125","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1002\/cncr.22059","article-title":"Differences in survival among patients with urachal and nonurachal adenocarcinomas of the bladder","volume":"107","author":"Wright","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.prp.2023.154379_bib126","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1159\/000362400","article-title":"Modified FOLFOX6 chemotherapy in patients with metastatic urachal cancer","volume":"59","author":"Yanagihara","year":"2013","journal-title":"Chemotherapy"},{"key":"10.1016\/j.prp.2023.154379_bib127","first-page":"5120","article-title":"Metastatic urachal cancer responding to FOLFOX chemotherapy","volume":"17","author":"Tran","year":"2010","journal-title":"Can. J. Urol."},{"key":"10.1016\/j.prp.2023.154379_bib128","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1111\/j.1442-2042.2006.01487.x","article-title":"Complete response of a recurrent advanced urachal carcinoma treated by S-1\/cisplatin combination chemotherapy","volume":"13","author":"Kojima","year":"2006","journal-title":"Int. J. Urol."},{"key":"10.1016\/j.prp.2023.154379_bib129","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1586\/14737140.6.12.1715","article-title":"Urachal carcinoma: surgical and chemotherapeutic options","volume":"6","author":"Siefker-Radtke","year":"2006","journal-title":"Expert Rev. Anticancer Ther."},{"key":"10.1016\/j.prp.2023.154379_bib130","series-title":"Textb. Uncommon Cancer","first-page":"18","article-title":"Uncommon cancers of the bladder","author":"Siefker-Radtke","year":"2006"},{"key":"10.1016\/j.prp.2023.154379_bib131","first-page":"E27","article-title":"A case of metastatic urachal adenocarcinoma treated with several different chemotherapeutic regimens","volume":"6","author":"Elser","year":"2012"},{"key":"10.1016\/j.prp.2023.154379_bib132","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/0090-4295(85)90121-9","article-title":"Chemotherapy for adenocarcinomas of bladder and urachal origin: 5-Fluorouracil, doxorubicin, and mitomycin-C","volume":"26","author":"Logothetis","year":"1985","journal-title":"Urology"},{"key":"10.1016\/j.prp.2023.154379_bib133","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1200\/JCO.2002.20.5.1361","article-title":"Phase III trial of fluorouracil, interferon alpha-2b, and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in metastatic or unresectable urothelial cancer","volume":"20","author":"Siefker-Radtke","year":"2002","journal-title":"J. Clin. Oncol. . J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.prp.2023.154379_bib134","doi-asserted-by":"crossref","first-page":"383","DOI":"10.3904\/kjim.2015.162","article-title":"Retrospective analysis of palliative chemotherapy for the patients with bladder adenocarcinoma: Korean Cancer Study Group Genitourinary and Gynecology Cancer Committee","volume":"33","author":"Kim","year":"2018","journal-title":"Korean J. Intern. Med"},{"key":"10.1016\/j.prp.2023.154379_bib135","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.3346\/jkms.2015.30.8.1143","article-title":"Survival outcomes and predictive factors for female urethral cancer: long-term experience with Korean patients","volume":"30","author":"Kang","year":"2015","journal-title":"J. Korean Med. Sci."},{"key":"10.1016\/j.prp.2023.154379_bib136","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1016\/j.ejso.2019.03.034","article-title":"Long-term survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for patients with peritoneal metastases of urachal cancer","volume":"45","author":"Mertens","year":"2019","journal-title":"Eur. J. Surg. Oncol."},{"key":"10.1016\/j.prp.2023.154379_bib137","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.eururo.2016.07.004","article-title":"Clinical sequencing-guided therapy of urachal carcinoma: new perspective for a rare cancer","volume":"70","author":"Nyir\u00e1dy","year":"2016","journal-title":"Eur. Urol."},{"key":"10.1016\/j.prp.2023.154379_bib138","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s10637-005-5860-y","article-title":"A phase I study of oral ZD 1839 given daily in patients with solid tumors: IND.122, a study of the Investigational New Drug Program of the National Cancer Institute of Canada Clinical Trials Group","volume":"23","author":"Goss","year":"2005","journal-title":"Invest. N. Drugs"},{"key":"10.1016\/j.prp.2023.154379_bib139","doi-asserted-by":"crossref","unstructured":"R.G. Amado, M. Wolf, M. Peeters, E. Van Cutsem, S. Siena, D.J. Freeman, T. Juan, R. Sikorski, S. Suggs, R. Radinsky, Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer, (2008).","DOI":"10.1200\/JCO.2007.14.7116"},{"key":"10.1016\/j.prp.2023.154379_bib140","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1056\/NEJMoa0804385","article-title":"K-ras mutations and benefit from cetuximab in advanced colorectal cancer","volume":"359","author":"Karapetis","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.prp.2023.154379_bib141","doi-asserted-by":"crossref","first-page":"4023","DOI":"10.1200\/JCO.2015.63.2471","article-title":"Combined BRAF and MEK inhibition with dabrafenib and trametinib in BRAF V600-mutant colorectal cancer","volume":"33","author":"Corcoran","year":"2015","journal-title":"J. Clin. Oncol. . J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.prp.2023.154379_bib142","doi-asserted-by":"crossref","first-page":"5705","DOI":"10.1200\/JCO.2008.18.0786","article-title":"Wild-type BRAF is required for response to panitumumab or cetuximab in metastatic colorectal cancer","volume":"26","author":"Di Nicolantonio","year":"2008","journal-title":"J. Clin. Oncol. . J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.prp.2023.154379_bib143","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1002\/1878-0261.12326","article-title":"Rapid proteomic analysis for solid tumors reveals LSD1 as a drug target in an end-stage cancer patient","volume":"12","author":"Doll","year":"2018","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.prp.2023.154379_bib144","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2017.35.15_suppl.4511","article-title":"Mismatch repair (MMR) detection in urothelial carcinoma (UC) and correlation with immune checkpoint blockade (ICB) response","volume":"35","author":"Iyer","year":"2017","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.prp.2023.154379_bib145","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1053\/j.gastro.2009.12.064","article-title":"Microsatellite instability in colorectal cancer","volume":"138","author":"Boland","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.prp.2023.154379_bib146","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1056\/NEJMoa022289","article-title":"Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer","volume":"349","author":"Ribic","year":"2003","journal-title":"New Engl. J. Med"},{"key":"10.1016\/j.prp.2023.154379_bib147","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s40425-017-0299-1","article-title":"Biomarkers for immunotherapy in bladder cancer: a moving target","volume":"5","author":"Aggen","year":"2017","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.prp.2023.154379_bib148","doi-asserted-by":"crossref","first-page":"v295","DOI":"10.1093\/annonc\/mdx371.001","article-title":"Final results of a phase I study of cabozantinib (cabo) plus nivolumab (nivo) and cabonivo plus ipilimumab (Ipi) in patients (pts) with metastatic urothelial carcinoma (mUC) and other genitourinary (GU) malignancies","volume":"28","author":"Nadal","year":"2017","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.prp.2023.154379_bib149","unstructured":"J.-L. Lee, A Multicenter Prospective Phase II Study of Modified FOLFIRINOX for 1st Line Treatment for Advanced Urachus Cancer, clinicaltrials.gov, 2020. \u3008https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04611724\u3009 (accessed January 12, 2023)."},{"key":"10.1016\/j.prp.2023.154379_bib150","unstructured":"M.D. Anderson Cancer Center, Phase II Trial of 5-FU, Leucovorin, Gemcitabine, and Cisplatin for Adenocarcinomas of the Urothelial Tract and Urachal Remnant, clinicaltrials.gov, 2022. \u3008https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00082706\u3009 (accessed January 12, 2023)."},{"key":"10.1016\/j.prp.2023.154379_bib151","unstructured":"National Cancer Institute (NCI), A Phase II Study of Ipilimumab, Cabozantinib, and Nivolumab in Rare Genitourinary Cancers (ICONIC), clinicaltrials.gov, 2023. \u3008https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03866382\u3009 (accessed January 12, 2023)."},{"key":"10.1016\/j.prp.2023.154379_bib152","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1159\/000368071","article-title":"Treatment outcome and relevance of palliative chemotherapy in urachal cancer","volume":"60","author":"Jung","year":"2014","journal-title":"Chemotherapy"},{"key":"10.1016\/j.prp.2023.154379_bib153","doi-asserted-by":"crossref","first-page":"574","DOI":"10.4111\/kju.2014.55.9.574","article-title":"Prognostic factors for urachal cancer: a bayesian model-averaging approach","volume":"55","author":"Kim","year":"2014","journal-title":"Korean J. Urol."},{"key":"10.1016\/j.prp.2023.154379_bib154","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/j.juro.2012.10.043","article-title":"Preoperative accuracy of diagnostic evaluation of the urachal mass","volume":"189","author":"Meeks","year":"2013","journal-title":"J. Urol."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033823000791?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033823000791?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T06:59:53Z","timestamp":1759733993000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033823000791"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":154,"alternative-id":["S0344033823000791"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2023.154379","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Urachal carcinoma: The journey so far and the road ahead","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2023.154379","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"154379"}}